Scarica l'app Stockscreener
7.58
1.04%
-0.08
Precedente Chiudi:
$7.66
Aprire:
$7.59
Volume 24 ore:
3,011
Relative Volume:
0.19
Capitalizzazione di mercato:
$51.41M
Reddito:
-
Utile/perdita netta:
$-71.37M
Rapporto P/E:
-0.7033
EPS:
-10.7782
Flusso di cassa netto:
$-46.62M
1 W Prestazione:
+0.00%
1M Prestazione:
+4.55%
6M Prestazione:
-13.47%
1 anno Prestazione:
-75.00%
Intervallo 1D:
$7.58
$7.64
Intervallo di 1 settimana:
$7.54
$7.81
Portata 52W:
$5.67
$33.83
Instil Bio Inc Stock (TIL) Company Profile
Nome
Instil Bio Inc
Settore
Industria
Telefono
(972) 499-3350
Indirizzo
3963 MAPLE AVENUE, DALLAS
Compare TIL vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TIL
Instil Bio Inc
|
7.58 | 50.39M | 0 | -71.37M | -46.62M | -10.78 |
VRTX
Vertex Pharmaceuticals Inc
|
546.12 | 136.93B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
827.72 | 85.11B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,033.15 | 64.95B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
145.55 | 53.23B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
210.02 | 45.38B | 742.00K | -1.37B | -1.07B | -7.0731 |
Instil Bio Inc Stock (TIL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2026-01-06 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-01-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-11-04 | Iniziato | JMP Securities | Mkt Perform |
| 2024-04-12 | Downgrade | Jefferies | Buy → Hold |
| 2022-11-01 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-11-01 | Downgrade | Truist | Buy → Hold |
| 2021-08-13 | Iniziato | Robert W. Baird | Outperform |
| 2021-04-13 | Iniziato | Cowen | Outperform |
| 2021-04-13 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-04-13 | Iniziato | Truist | Buy |
Mostra tutto
Instil Bio Inc Borsa (TIL) Ultime notizie
Why (TIL) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Instil Bio, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Form 8K Instil Bio Inc For: 13 August By Investing.com - Investing.com Nigeria
Instil Bio Reports Second Quarter 2026 Financial Results - Intellectia AI
Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update - The Manila Times
Instil Bio Reports $4.3 Million Second-Quarter 2026 Net Loss - Quiver Quantitative
Instil Bio, Inc. 2026: Revenue ($4.35M), Net income ($4.3M), EPS ($0.63) — 10-Q Summary - TradingView
Instil Bio reports Q2 2026 net loss $4.3M, cash and marketable securities $69.9M - TradingView
Instil Bio (TIL) slashes R&D spend and leans on Tarzana lease income in Q2 2026 - Stock Titan
Instil Bio expects $69.9M cash to fund plan beyond 2027 - Stock Titan
Instil Bio (Nasdaq: TIL) trims Q2 2026 loss and extends cash runway - Stock Titan
Instil Bio (TIL) Dips 2.7% as Shares Hover Near Key SupportJurik MA - vinanet.vn
Instil Bio Inc (TIL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TIL Q1 2026 Earnings: Wider-than-Expected Loss as Clinical Pipeline Execution Takes Center StageEarnings Volatility Report - vinanet.vn
Instil Bio (TIL) Edges Higher: Biotech Stock Holds Above Key SupportPut Dominated - vinanet.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Instil Bio, Inc. (TIL) And Encourages Investors to Connect - The National Law Review
Instil Bio, Inc. expected to post a loss of 43 cents a shareEarnings Preview - TradingView
Instil Bio Inc (TIL) Stock News Today - TradingKey
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Instil Bio Q1 2026 Earnings: EPS Miss Reflects Continued Pre-Clinical-Stage InvestmentFinancial Summary - vinanet.vn
TIL Q2'26 Earnings: revenue estimate is 0 USD - TradingView
Instil Bio (TIL) Edges Lower Near Key Support LevelsOvervalued Signals - vinanet.vn
Instil Bio Inc (TIL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TIL|Instil Bio Inc|Price:7.380|Chg%:-0.030 - TradingKey
Instil Bio Inc (TIL) Balance Sheet - TradingKey
Instil Bio Inc (TIL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Instil Bio Inc (TIL) Income Statement - TradingKey
Instil Bio Inc (TIL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TIL|Instil Bio Inc|Price:7.130|Chg%:-0.070 - TradingKey
Instil Bio Inc (TIL) Cash Flow - TradingKey
Instil Bio, Inc. Revenue Breakdown – NASDAQ:TIL - TradingView
TIL|Instil Bio Inc|Price:7.430|Chg%:+0.040 - TradingKey
Instil Bio Inc (TIL) Institutional Confidence - TradingKey
Instil Bio Inc (TIL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Avoiding Lag: Real-Time Signals in (TIL) Movement - Stock Traders Daily
TIL Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Continues to Burn CashEarnings Miss Streak - vinanet.vn
TIL Q1 2026 Earnings: Wider-than-expected loss as pre-revenue biotech continues developmentGrowth Acceleration Report - vinanet.vn
TIL Q1 2026 Earnings: Wider-than-Expected Loss Highlights Ongoing ChallengesEarnings Quality Score - Vinanet
Instil Bio Inc. (TIL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Reports Wider Loss - DonanımHaber
Instil Bio (TIL) edges higher as shares test key support-resistance rangeTriangle Correction - DonanımHaber
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (TIL) Investors to Inquire about Securities Investigation - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Instil Bio, Inc. (T - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Discipline and Rules-Based Execution in TIL Response - Stock Traders Daily
Enterprise value to EBIT forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
Price to book forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
Price to sales forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
Price to earnings forward of Instil Bio, Inc. – NASDAQ:TIL - TradingView
TIL Q1 2026 Earnings: EPS Miss Reflects Increased R&D Spend as Pipeline AdvancesOne-Time Gain Impact - dars.gov.et
Instil Bio, Inc. Actuals & Estimates (NASDAQ:TIL) - TradingView
5GT0 Forecast — Price Target — Prediction for 2027 - TradingView
Instil Bio Inc Azioni (TIL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Instil Bio Inc Azioni (TIL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Laumas Sandeep | CFO and CBO |
Sep 10 '25 |
Sale |
23.39 |
30,000 |
701,667 |
0 |
0.86%
0.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):